Evaluation of culture and sensitivity guided antibiotic selection in eradication of helicobacter pylori

Hussam Ali Hussein Ali;

Abstract


The Aim of this study is to assess the value of using the culture-guided Antibiotic sensitivity versus standard triple therapy in successful H. pylori eradication

43 of group A patient (86%) showed successful h. pylori eradication after culture guided antibiotic therapy.

0nly 20 of group B patients (60%) showed successful h. pylori eradication after standard triple therapy.

The study showed high resistant rates of h. pylori to clarithromycin and amoxicillin and metronidazole and gradually increasing resistance against levofloxacin.

Countries like Egypt seem to have a high clarithromycin resistance, and a large-scale clinical trial is needed to choose the first-line therapy for eradication of H. pylori infection.

Unfortunately, many patients infected with H. pylori in whom treatment has failed, have concurrent dual resistance to clarithromycin and metronidazole, or even triple resistance to clarithromycin, metronidazole, and fluoroquinolone (using culture-based antimicrobial susceptibility testing).
Given the alarmingly high antibiotic resistance in H. pylori, gastroenterologists should change the empiric H. pylori treatment to an antimicrobial susceptibility testing-guided precision treatment.

Culture guided therapy is expensive and laborious but as the results showed, it is definitely the best method to achieve complete h. pylori eradication from the first time.


Other data

Title Evaluation of culture and sensitivity guided antibiotic selection in eradication of helicobacter pylori
Other Titles تقييم اختيار المضادات الحيوية بناء علي نتيجة المزرعة و الحساسية للقضاء علي ميكروب الهليكوباكتر بيلوري
Authors Hussam Ali Hussein Ali
Issue Date 2020

Attached Files

File SizeFormat
BB8694.pdf956.03 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.